Live Cell Imaging Market Is Expected To Reach US$ 7 Billion By 2022 : Radiant Insights,Inc

June 05 14:36 2017

Radiant Insights,Inc
The new report introduced entitled “Live Cell Imaging Market Outlook 2022”, includes a comprehensive analysis of the current and future outlooks of the Live Cell Imaging industry. The live cell imaging market is expected to reach US$ 7 Billion by 2022.

Live Cell Imaging is defined as the study of living cells using high content screening or analysis systems and imaging systems such as microscopes, cell analyzers, etc. These technologies are used in number of investigations in order to provide critical insights into the fundamental nature of tissue and cellular function.

Complete Report Available @ http://www.radiantinsights.com/research/live-cell-imaging-market-outlook-2022

The report presents an in-depth analysis of several techniques used in imaging of live cells; as well as the segmentation of market by products, applications, technology and geography. Based on product types, the market has been segmented into equipments, consumables and softwares. Equipment market is expected to account for the largest share in 2016. According to technologies used in live cell imaging, the market has been divided into FRET, FISH, and other major techniques.

Similarly, geographical regions include North America, Europe, Asia Pacific and Rest of the World. North America is the largest market for live cell imaging due to high number of cell biology researches conducted in the region. As per RNCOS’ analysis, live cell imaging is widely entering into a number of fields such as cell biology, developmental biology, drug discovery, stem cell biology, neurobiology and electrophysiology. It is emerging as a powerful tool for providing critical insights into cell function, including dynamic processes in living cells with nano-scale resolution in real time. Recent advances in microscopy techniques such as fluorescence light microscopy, including super resolution, photo activation, etc. and confocal microscopy are moving live cell imaging for a number of applications.

Request A Sample Copy Of This Report at: http://www.radiantinsights.com/research/live-cell-imaging-market-outlook-2022/request-sample

The last section of the report discusses about the prominent players in global live cell imaging market. A brief business overview and financial information about each of these players has been provided along with their product portfolios. The recent development and strength weakness analysis of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global live cell imaging market.

Explore Other Reports By Radiant Insights,Inc at

  • US Proton Therapy Market –

http://www.radiantinsights.com/research/us-proton-therapy-market-forecast-to-2022

The report, “US Proton Therapy Market Forecast to 2022” covers the current and future analysis of US proton therapy market. Furthermore, analysis of the existing and upcoming proton therapy centers in the US, along with an estimation of the shortage of proton centers in the current and future scenario is also provided, which is intended to help players extract benefits from the largely untapped but lucrative proton therapy market. The report also offers state-wise statistics of potential patients for proton therapy, and the current market penetration. According to the report, by 2022, the US will have 38 proton therapy centers. Consequently, the market will attain revenue of around US$ 1 Billion by 2022, growing at a CAGR of over 16% during the forecast period (2015-2022).

 

  • Cancer Generics Market –

http://www.radiantinsights.com/research/global-cancer-generics-market-forecast-to-2022

Global Cancer Generics Market Forecast is anticipated to witness a double digit growth during 2016-2022. This report provides a detailed analysis of the current and future market scenario of the global cancer generics market. The report provides insight about the major drivers and challenges, along with the latest trends and developments impacting the industry growth. In addition, the report also highlights various opportunities available for growth of the global cancer generics market.

 

  • CRISPR/Cas9 Market –

http://www.radiantinsights.com/research/global-crispr-cas9-market-outlook-2022

The advent of CRISPR/Cas9 has revolutionized the Genome Editing Industry. This technique is allowing a previously unattainable level of genomic targeting with greater efficiency and simplicity. Due to this ability, the share of CRISPR/Cas9 is incessantly increasing in the Genome Editing Industry. It is anticipated that the global CRISPR/Cas9 market will cross US$ 1.5 Billion by 2022. The growth of the market is likely to be driven by expanding drug discovery applications and increasing research related activities for exploring CRISPR/Cas9 therapeutic applications.

About Radiant Insight

Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake. 

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: Send Email
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.radiantinsights.com/research/live-cell-imaging-market-outlook-2022

  Categories: